The overlap of ACTN4 amplification with aggressive histological subtypes makes it difficult to definitively determine whether ACTN4 amplification is an independent driver of tumor aggressiveness or a surrogate marker of this phenotype. This evidence concerns the gene ACTN4 and neoplasm.